Literature DB >> 13629463

Imipramine (tofranil): a safe, effective antidepressant drug in private practice.

M STRAKER.   

Abstract

Entities:  

Keywords:  DEPRESSION/therapy; TRANQUILIZING AGENTS/therapeutic use

Mesh：

Substances：

Year:  1959        PMID： 13629463      PMCID： PMC1830976     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  The treatment of depressive conditions with imipramine (G 22355).

Authors:  H E LEHMANN; C H CAHN; R L DE VERTEUIL
Journal:  Can Psychiatr Assoc J       Date:  1958-10

2.  The treatment of depressive states with G 22355 (imipramine hydrochloride).

Authors:  R KUHN
Journal:  Am J Psychiatry       Date:  1958-11       Impact factor: 18.112

3.  The double blind method: its pitfalls and fallacies.

Authors:  W TUTEUR
Journal:  Am J Psychiatry       Date:  1958-04       Impact factor: 18.112

4.  Therapeutic results in mental hospitals with a minimum of professional personnel.

Authors:  L H BARTEMEIER
Journal:  Am J Psychiatry       Date:  1956-12       Impact factor: 18.112

5.  The personal element in psychiatric research.

Authors:  P E FELDMAN
Journal:  Am J Psychiatry       Date:  1956-07       Impact factor: 18.112
  5 in total
  5 in total

1.  A controlled trial of imipramine in treatment of depressive states.

Authors:  J R BALL; L G KILOH
Journal:  Br Med J       Date:  1959-11-21

2.  Clinical Evaluation of a New Antidepressant Agent: Tranylcypromine with Trifluoperazine (Parstelin).

Authors:  M Straker
Journal:  Can Med Assoc J       Date:  1960-12-17       Impact factor: 8.262

3.  Use of imipramine (tofranil) in the aged chronically ill.

Authors:  M STRAKER; E M ROTH
Journal:  Can Med Assoc J       Date:  1960-02-13       Impact factor: 8.262

4.  Imipramine (tofranil) in mental health clinic and private practice.

Authors:  B V EARLE; A M EARLE
Journal:  Can Med Assoc J       Date:  1960-10-08       Impact factor: 8.262

Review 5.  Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects.

Authors:  Brigitte A Brouwer; Bianca T A de Greef; Janneke G J Hoeijmakers; Margot Geerts; Maarten van Kleef; Ingemar S J Merkies; Catharina G Faber
Journal:  Drugs Aging       Date:  2015-08       Impact factor: 3.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.